Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Perlman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
American Journal of Obstetrics and Gynecology|June 1, 1988
Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of northern California womenJ A Perlman, P H Wolf, R Ray, et al.
Surgery, Gynecology & Obstetrics|May 1, 1979
Hyperfunctioning supernumerary parathyroid glandsC Wang, J E Mahaffey, L Axelrod, et al.
American Journal of Obstetrics and Gynecology|August 1, 1985
Long-term risk of menstrual disturbances after tubal sterilizationF DeStefano, J A Perlman, H B Peterson, et al.
Journal of Chronic Diseases|January 1, 1987
Impaired glucose tolerance in women using oral contraceptives: United States, 1976-1980R Russell-Briefel, T M Ezzati, J A Perlman, et al.
JAMA|August 11, 1993
Vasectomy and increased risk of prostate cancerJ A Perlman, O W Brawley, L G Ford, et al.
Journal of the National Cancer Institute|May 19, 1993
Re: Chemoprevention studies in the community clinical oncology programK A Johnson, O W Brawley, J A Perlman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factorsR M Watanabe, C G Azen, S Roy, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
HIV risk difference between condom users and nonusers among U.S. heterosexual womenJ A Perlman, J Kelaghan, P H Wolf, et al.
Preventive Medicine|July 1, 1986
Cardiovascular risk status and oral contraceptive use: United States, 1976-1980R Russell-Briefel, T M Ezzati, R Fulwood, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
5-Alpha-reductase inhibition and prostate cancer preventionO W Brawley, L G Ford, I Thompson, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Obstetrics and Gynecology|June 1, 1988
Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of northern California womenJ A Perlman, P H Wolf, R Ray, et al.
Surgery, Gynecology & Obstetrics|May 1, 1979
Hyperfunctioning supernumerary parathyroid glandsC Wang, J E Mahaffey, L Axelrod, et al.
American Journal of Obstetrics and Gynecology|August 1, 1985
Long-term risk of menstrual disturbances after tubal sterilizationF DeStefano, J A Perlman, H B Peterson, et al.
Journal of Chronic Diseases|January 1, 1987
Impaired glucose tolerance in women using oral contraceptives: United States, 1976-1980R Russell-Briefel, T M Ezzati, J A Perlman, et al.
JAMA|August 11, 1993
Vasectomy and increased risk of prostate cancerJ A Perlman, O W Brawley, L G Ford, et al.
Journal of the National Cancer Institute|May 19, 1993
Re: Chemoprevention studies in the community clinical oncology programK A Johnson, O W Brawley, J A Perlman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factorsR M Watanabe, C G Azen, S Roy, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
HIV risk difference between condom users and nonusers among U.S. heterosexual womenJ A Perlman, J Kelaghan, P H Wolf, et al.
Preventive Medicine|July 1, 1986
Cardiovascular risk status and oral contraceptive use: United States, 1976-1980R Russell-Briefel, T M Ezzati, R Fulwood, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
5-Alpha-reductase inhibition and prostate cancer preventionO W Brawley, L G Ford, I Thompson, et al.
Pageof 3